KCT0008623招募中未知
A 12-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Angelica gigas Nakai extract(AGE232) on improvement of blood flow
Astrogenesis0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 25(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •1) Male or female subjects aged from 25 to 70 years old
- •2) Those who satisfy 3 or more criteria
- •? Subjects who 200~239 mg/dL of fasting total-cholesterol
- •? Subjects who130~159 mg/dL of fasting LDL-cholesterol
- •? Subjects who 100~125 mg/dL of fasting blood sugar
- •? Subjects who 120~139 mmHg of systolic blood pressure
- •? Subjects who BMI 25~29.9 kg/m2 of BMI
- •? Subjects who male 0.9, female 0.85 of WHR
排除标准
- •1) Subjects who have disorders in platelet function and platelet coagulation
- •2) Subjects who BMI 25~29.9 kg/m2 of BMI
- •3) Subjects who have taken medications or dietary supplements related to platelet function, blood circulation improvement, and hyperlipidemia within 4 weeks before study enrollment
- •4) Subjects who Alcoholism (21 units/week) or substance abuse or dependence
- •5) Subjects who have an overreaction to the ingredients contained in the human body application test product
- •6) Women undergoing hormone replacement therapy
- •7) Participation in other clinical trials within the previous three months
- •8) Subjects who are pregnant and breastfeeding female
- •9) Subjects who do not perform adequate contraception in the urban eligible women (except the woman who undergo sterilization operation)
- •10) Subject who was deemed inappropriate to participate in this clinical trial by the research director due to other reasons including screening test
研究者
相似试验
招募中
Unknown
A human trial of SMSP8118 on improvement of Liver functioDiseases of the digestive systemKCT0009369Jeonbuk National University Hospital80
进行中（未招募）
不适用
A 12-week, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the efficacy, safety and tolerability of darifenacin (7.5 mg o.d. with voluntary up-titration to 15 mg o.d.) in patients aged = 65 years with overactive bladder - Not applicableOveractive bladder (OAB)EUCTR2004-002894-21-DEovartis Pharma Services AG399
招募中
Unknown
Clinical trial to evaluate the effectiveness and safety of EEFE on cognitive function improvementKCT0009469Ewha Womens University80
招募中
不适用
A 12-week, randomized, double-blind, placebo-controlled human application trial to evaluate the efficacy and safety of ACP_01 on skin wrinkle improvement and moisturizingKCT0007720Daehan Chemtech Co., Ltd100
招募中
不适用
Evalution of the Effectiveness and Safety of ChondroT on the Knee ArthritisKCT0007997Dongshin University Mokpo Oriental Hospital160